Evidence map›Paper›PMID 35892202›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Analysis of cell-specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction.

Ben Nicholas, Jane Guo, Hyun-Hee Lee, Alistair Bailey, Rene de Waal Malefyt, Milenko Cicmil, Ratko Djukanovic

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Solute Carrier Family 26 Member 4 (SLC26A4), A Potential Therapeutic Target for Asthma.Journal of respiratory biology and translational medicine · 2024
    Article
  2. Article
  3. Olfactomedin 4 as a circulating biomarker for asthma.Annals of translational medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ben NicholasDivision of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, UK.ORCID 0000-0003-1467-9643
Jane GuoOncology & Immunology Discovery, Merck Research Laboratories, Boston, Massachusetts, USA.
Hyun-Hee LeeOncology & Immunology Discovery, Merck Research Laboratories, Boston, Massachusetts, USA.
Alistair BaileyCancer Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, UK.ORCID 0000-0003-0023-8679
Rene de Waal MalefytMerck Research Laboratories, Palo Alto, California, USA.ORCID 0000-0002-2663-383X
Milenko CicmilOncology & Immunology Discovery, Merck Research Laboratories, Boston, Massachusetts, USA.
Ratko DjukanovicDivision of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, UK.ORCID 0000-0001-6039-5612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaHypersensitivityBiomarkersHumansImmunity, InnateBiomarkersallergyasthmabiomarkersperipheraltranscriptomic

Identifiers

PMID35892202
PMCPMC9804525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.